Skip to content

2021 MIPS Improvement Activity IA_PSPA_31: Patient Medication Risk Education


Activity Description

In order to receive credit for this activity, MIPS eligible clinicians must provide both written and verbal education regarding the risks of concurrent opioid and benzodiazepine use for patients who are prescribed both benzodiazepines and opioids. Education must be completed for at least 75% of qualifying patients and occur: (1) at the time of initial co-prescribing and again following greater than 6 months of co- prescribing of benzodiazepines and opioids, or (2) at least once per MIPS performance period for patients taking concurrent opioid and benzodiazepine therapy.

Activity ID Activity Weighting Sub-Category Name
IA_PSPA_31 High Patient Safety and Practice Assessment